Walleye Trading
ANIK icon

Walleye Trading’s Anika Therapeutics ANIK Stock Holding History

Walleye Trading’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,700
Closed -$110K – 5111
2021
Q1 		$110K Sell
2,700
-1,800
-40% -$68.3K ﹤0.01% 4040
2020
Q4 		$204K Sell
4,500
-9,200
-67% -$349K ﹤0.01% 3502
2020
Q3 		$485K Sell
13,700
-23,800
-63% -$860K ﹤0.01% 2265
2020
Q2 		$1.42M Buy
37,500
+27,000
+257% +$890K 0.01% 1385
2020
Q1 		$304K Buy
10,500
+5,100
+94% +$206K ﹤0.01% 2277
2019
Q4 		$280K Sell
5,400
-700
-11% -$40.7K ﹤0.01% 2872
2019
Q3 		$335K Buy
6,100
+2,800
+85% +$144K ﹤0.01% 2487
2019
Q2 		$134K Sell
3,300
-12,300
-79% -$448K ﹤0.01% 3174
2019
Q1 		$472K Buy
+15,600
New +$534K ﹤0.01% 2330
2018
Q4 		– Sell
-2,500
Closed -$105K – 4582
2018
Q3 		$105K Sell
2,500
-3,800
-60% -$150K ﹤0.01% 4191
2018
Q2 		$202K Buy
+6,300
New +$259K ﹤0.01% 3639

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Walleye Trading's ANIK Position: Q2 2021 in Review

Walleye Trading sold out of Anika Therapeutics (ANIK) in Q2 2021, closing a stake of 4,922 shares — an estimated $201K sold.

Walleye Trading first reported a position in ANIK in Q4 2015 and held it in 10 quarters. The position peaked at $359K in Q2 2018. 139 funds tracked by Wall St. Rank hold ANIK as of Q2 2021.

  • Walleye Trading reported no remaining Anika Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Walleye Trading sold 4,922 Anika Therapeutics shares in Q2 2021, an estimated $201K.
  • Walleye Trading first reported a position in Anika Therapeutics in Q4 2015 and held it in 10 quarters.
  • Walleye Trading's Anika Therapeutics position peaked at $359K in Q2 2018.
  • 139 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2021.

Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.